Hca Healthcare Inc (HCA) Cumulative Dividend Pay out History TTM by Quarter, Fundamentals - CSIMarket
CSIMarket
 


Hca Healthcare Inc   (NYSE: HCA)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

 

HCA's Dividend Pay out ratio over the 12 Months Period

Cumulative by Quarter, Trailing twelve months




Hca Healthcare Inc 's 12 Months dividend pay out ratio, the ratio that measures the proportion of earnings, that Hca Healthcare Inc ' distributes to its shareholders in the form of dividends, sequentially decreased to 10.22% in the first quarter 2026, this result is above Hca Healthcare Inc 's average of of 22.47%.

Within Healthcare sector 44 other companies have achieved higher 12 Months dividend pay out ratio. While in terms of ranking among all other companies, the company has moved form 340 in the fourth quarter 2025, to 493.


Dividend in Glossary



Cumulative Dividend Pay out Ratio I. Quarter
(Mar 31 2026)
IV. Quarter
(Dec 31 2025)
III. Quarter
(Sep 30 2025)
II. Quarter
(Jun 30 2025)
I. Quarter
(Mar 31 2025)
HCA's Pay out Ratio (TTM) 10.22 % 10.26 % 10.97 % 11.68 % 12.09 %
HCA's Dividend Pay out Ratio Total Ranking # 493 # 340 # 439 # 1116 # 476

  News about Hca Healthcare Inc Dividends

HCA Healthcare's Dual Triumph: Robust Financial Growth and Strategic Community Investment,

HCA Healthcare Finances Show Resilience Amid Strategic Community InvestmentsIn a robust display of financial strength and organizational commitment to community welfare, HCA Healthcare, Inc. (NYSE: HCA), headquartered in Nashville, Tennessee, has released its financial and operating results for the first quarter ending March 31, 2025. Despite navigating an increasingly complex healthcare landscape, the organization has demonstrated both fiscal success and a continued emphasis on social responsibility.First Quarter Financial HighlightsHCA Healthcare reported impressive financial metrics for the first quarter, with revenues reaching a substantial $18.321 billion. This performance marks a key period of growth and strategic advancement across the company's expansive healthcare operations.

HCA Healthcare Impresses with Strong Q2 2024 Results, Securing Investor Confidence

HCA Healthcare Reports Strong Second Quarter 2024 Results: A Testimony to Commitment to Shareholders
NASHVILLE, Tenn. - HCA Healthcare, Inc. (NYSE: HCA) released its financial and operating results for the second quarter ended June 30, 2024, showcasing impressive performance and a firm commitment to its shareholders. The company reported total revenues of $17.492 billion, demonstrating its continued growth and success.
Net income attributable to HCA Healthcare for the quarter amounted to $1.461 billion, or $5.53 per diluted share. This robust financial performance highlights the company's ability to navigate challenges and capitalize on opportunities effectively. HCA Healthcare's adjusted EBITDA totaled $3.550 billion, further underscoring its strong market position and operational efficiency.

HCA Healthcare Soars to New Heights in Second Quarter 2024, Impresses Investors with Strong Financial Performance

HCA Healthcare Excels in Second Quarter 2024, Demonstrates Strong Financial Performance
After analyzing the financial and operating results of HCA Healthcare for the second quarter of 2024, it is evident that the company has achieved impressive growth and success. With revenues totaling $17.492 billion and net income of $1.461 billion, HCA Healthcare has shown its capability to generate substantial profits. The adjusted EBITDA of $3.550 billion and cash flows from operating activities amounting to $1.971 billion further highlight the company's financial strength.
One key aspect to note is HCA Healthcare's commitment to shareholders, as reflected in the 12 Months dividend pay out ratio. Despite facing stiff competition in the Healthcare sector, HCA Healthcare Inc stands out as a top performer. The company's ranking surpasses 1247 in the second quarter of 2023, showcasing its strong position within the industry.

Interesting HCA Healthcare Announces Impressive 2023 Q4 Results; Analysts Optimistic of Stellar Performance in 2024


HCA Healthcare, Inc. (HCA), a leading provider of healthcare services, recently unveiled its financial and operational performance for the fourth quarter ended December 31, 2023. These results highlight the company's continued commitment to delivering healthcare at its best, while simultaneously keeping an eye on strategic growth and financial stability.
During the fourth quarter, HCA Healthcare, Inc. managed to achieve a revenue of $17.303 billion, underscoring a robust financial performance. In addition to this, the company reported a net income of $1.607 billion, or $5.93 per diluted share, rounding out the year with a solid financial standing.
The company also recorded an Adjusted EBITDA of $3.618 billion, further demonstrating its financial strength. It is worth noting that the EBITDA is one of the most widely-used profitability ratios, reflecting earnings before interest, tax, depreciation, and amortization. The high figure highlights the company's efficiency in managing its core operations and profitability.


HCA's Dividend Pay out Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 5
Healthcare Sector # 45
S&P 500 # 493

Dividend Pay out Ratio Statistics
High Average Low
186.25 % 22.47 % 0.28 %
(Dec 31 2012)   (Dec 31 2015)



Other Dividend Ratios
Highest Ranking Dividend Yield
Lowest Ranking Dividend Yield
Annual Dividend Pay out for HCA
HCA's Dividend Yield




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.